Abstract
Pancreatic and periampullary cancer affects individuals all over the world and is one of the leading causes of cancer-related deaths. It was recently estimated that 250,000 individuals are annually afflicted with this cancer. While there was a slight decrease in pancreatic cancer a few years ago, it is now becoming more evident that the incidence of this malignancy is on the rise. In India, too, the incidence of pancreatic and periampullary cancer was noted to be increasing.
Recent efforts have thus focused on trying to improve survival further in patients amenable to resection by the addition of chemotherapy and radiotherapy in the adjuvant setting. In patients with locally advanced disease, attempts have been made to downstage the cancer by administering neoadjuvant chemotherapy alone or chemoradiotherapy and aggressive surgery, thereafter.
This chapter provides a concise, evidence-based perspective on the management of pancreatic and periampullary cancer.
Recent efforts have thus focused on trying to improve survival further in patients amenable to resection by the addition of chemotherapy and radiotherapy in the adjuvant setting. In patients with locally advanced disease, attempts have been made to downstage the cancer by administering neoadjuvant chemotherapy alone or chemoradiotherapy and aggressive surgery, thereafter.
This chapter provides a concise, evidence-based perspective on the management of pancreatic and periampullary cancer.
| Original language | English |
|---|---|
| Title of host publication | Textbook of Surgical Gastroenterology |
| Editors | Pramod Mishra |
| Publisher | Jaypee Brothers Medical Publishers |
| Chapter | 42 |
| Pages | 485-493 |
| Number of pages | 9 |
| ISBN (Print) | 9789351529989 |
| Publication status | Published - 2016 |
Keywords
- Pancreatic cancer
- Periampullary cancer
- Adjuvant chemotherapy
- Adjuvant chemoradiotherapy
